AdAlta Shareholder Update June 2018
Read MoreNews & Media – old
AdAlta seeking Head of Drug Discovery
Read MoreAdAlta to advance improved lung fibrosis therapy, AD-214
Read MoreCEO Sam Cobb speaks with Health Radio Online
Read MorePublication of AD-114 Demonstrates Anti-Fibrotic Effects in Preclinical Models of Lung Fibrosis
Read MoreThe commercial potential of targeting the complex proteins GPCRs and ion channels
Read MoreCEO Sam Cobb speaks to Health Invest TV
Read MoreResearcher looks to next generation antibody treatment for Chronic Kidney Disease
Read MoreAdAlta to present at the Biotech Showcase in San Francisco
Read MoreMorgans Interview with CEO Sam Cobb
Read More
